chr2-27858561-G-A
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_022128.3(RBKS):c.100C>T(p.Arg34Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000967 in 1,612,724 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R34H) has been classified as Uncertain significance.
Frequency
Consequence
NM_022128.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RBKS | NM_022128.3 | c.100C>T | p.Arg34Cys | missense_variant | 2/8 | ENST00000302188.8 | |
RBKS | NM_001287580.2 | c.-102C>T | 5_prime_UTR_variant | 3/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RBKS | ENST00000302188.8 | c.100C>T | p.Arg34Cys | missense_variant | 2/8 | 1 | NM_022128.3 | P1 | |
RBKS | ENST00000449378.1 | c.*1027C>T | 3_prime_UTR_variant, NMD_transcript_variant | 3/9 | 1 | ||||
MRPL33 | ENST00000448427.1 | c.165-35972G>A | intron_variant, NMD_transcript_variant | 4 | |||||
RBKS | ENST00000453412.1 | c.*123C>T | 3_prime_UTR_variant, NMD_transcript_variant | 3/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152138Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000599 AC: 15AN: 250430Hom.: 0 AF XY: 0.0000591 AC XY: 8AN XY: 135424
GnomAD4 exome AF: 0.0000972 AC: 142AN: 1460586Hom.: 0 Cov.: 30 AF XY: 0.0000991 AC XY: 72AN XY: 726690
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152138Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2021 | The c.100C>T (p.R34C) alteration is located in exon 2 (coding exon 2) of the RBKS gene. This alteration results from a C to T substitution at nucleotide position 100, causing the arginine (R) at amino acid position 34 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at